Deborah Knobelman
2022
In 2022, Deborah Knobelman earned a total compensation of $1.1M as Chief Financial Officer, Treasurer and Head of Corporate Development at Senti Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $169,992 |
|---|---|
| Option Awards | $428,208 |
| Salary | $424,981 |
| Stock Awards | $75,000 |
| Other | $5,244 |
| Total | $1,103,425 |
Knobelman received $428.2K in option awards, accounting for 39% of the total pay in 2022.
Knobelman also received $170K in non-equity incentive plan, $425K in salary, $75K in stock awards and $5.2K in other compensation.
Rankings
In 2022, Deborah Knobelman's compensation ranked 2,833rd out of 5,736 executives tracked by ExecPay. In other words, Knobelman earned more than 50.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,833 out of 5,736 | 51st |
Division Manufacturing | 1,581 out of 3,125 | 49th |
Major group Chemicals And Allied Products | 732 out of 1,416 | 48th |
Industry group Drugs | 684 out of 1,317 | 48th |
Industry Biological Products, Except Diagnostic Substances | 166 out of 291 | 43rd |
Source: SEC filing on April 28, 2023.
Knobelman's colleagues
We found two more compensation records of executives who worked with Deborah Knobelman at Senti Biosciences in 2022.